Once again, a new strain of COVID has hit the country, and that includes the state of Massachusetts. According to the Centers for Disease Control and Prevention (CDC), as of early June, the new strain ...

During his Senate confirmation hearings, Health Secretary Robert F. Kennedy Jr. suggested he wouldn’t undermine vaccines. “I ...

Writing in JAMA, four former government officials warn that the Trump administration’s involvement in delaying the approval ...

Peter Marks, who headed the FDA’s Center for Biologics Evaluation and Research before being forced to resign in March, said the agency’s new risk-based COVID-19 vaccine framework contradicts the ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

Shares of San Diego-based Cidara Therapeutics Inc. (NASDAQ:CDTX) were trading at $40.41, up $19.39, or 92%, on positive top-line results from its randomized, double-blind, placebo-controlled phase IIb ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

Novavax (NASDAQ:NVAX) shares fell on Tuesday after Citi started its coverage of the COVID shot maker with a Sell recommendation and a price target of $6, citing among other issues concerns over the ...

It’s worth noting that myocarditis is not unique to mRNA vaccines, as it’s also a rare side effect of Novavax’s protein-based ...

Government advisers are split on whether drugmakers should update their COVID-19 vaccines to better protect Americans this fall and winter.

Trump admin's new FDA update limits annual COVID shots to high-risk groups, ending routine access for healthy kids and adults.